Pictet Asset Management Holding Sa Regeneron Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $98.2 Billion
- Q3 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 323,370 shares of REGN stock, worth $224 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
323,370
Previous 304,127
6.33%
Holding current value
$224 Million
Previous $160 Million
13.88%
% of portfolio
0.19%
Previous 0.17%
Shares
9 transactions
Others Institutions Holding REGN
# of Institutions
1,467Shares Held
86.5MCall Options Held
2.42MPut Options Held
1.64M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...